Nodding syndrome

Emerging Infectious Diseases

Volumn 19, Issue 9, 2013, Pages 1374-1384

  Dowell, Scott F ^a   Sejvar, James J ^a   Riek, Lul ^b   Vandemaele, Katelijn A H ^c   Lamunu, Margaret ^c   Kuesel, Annette C ^c   Schmutzhard, Erich ^d   Matuja, William ^e   Bunga, Sudhir ^a   Foltz, Jennifer ^a   Nutman, Thomas B ^f   Winkler, Andrea S ^g   Mbonye, Anthony K ^h,i  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b Ministry of Health   (Sudan)

^c WORLD HEALTH ORGANIZATION   (Switzerland)

^d UNIVERSITY OF INNSBRUCK   (Austria)

^e MUHIMBILI UNIVERSITY OF HEALTH AND ALLIED SCIENCES   (Tanzania)

^f NATIONAL INSTITUTES OF HEALTH   (United States)

^g TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^h MINISTRY OF HEALTH   (Uganda)

ⁱ MAKERERE UNIVERSITY   (Uganda)

Author keywords

[No Author keywords available]

Indexed keywords

IVERMECTIN; PHENOBARBITAL; PHENYTOIN; PYRIDOXINE;

ARTICLE; ATONIC SEIZURE; CEREBROSPINAL FLUID ANALYSIS; CLINICAL EVALUATION; CLINICAL FEATURE; CLINICAL TRIAL (TOPIC); COGNITIVE DEFECT; DEATH; DRUG MEGADOSE; ELECTROENCEPHALOGRAPHY; HUMAN; INCIDENCE; INFECTION; NEUROLOGIC DISEASE; NODDING SYNDROME; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; ONCHOCERCIASIS; PYRIDOXINE DEFICIENCY; PYRIDOXINE DEPENDENT SEIZURE; RISK FACTOR; SEIZURE; SEROLOGY;

AFRICA; EPIDEMIC; EPILEPSY; HEAD NODDING; IDIOPATHIC; NODDING SYNDROME; ONCHOCERCIASIS; PARASITES; SEIZURES; SOUTH SUDAN; UGANDA;

ADOLESCENT; ADULT; AFRICA; AGE FACTORS; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; ELECTROENCEPHALOGRAPHY; FEMALE; GEOGRAPHY, MEDICAL; HUMANS; INCIDENCE; INFANT; MAGNETIC RESONANCE IMAGING; MALE; NODDING SYNDROME; YOUNG ADULT;

EID: 84882651226     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1909.130401     Document Type: Article

References (40)

1. Lacey M. Nodding disease: mystery of southern Sudan. Lancet Neurol. 2003;2:714. http://dx.doi.org/10.1016/S1474-4422(03)00599-4
2. Tumwine JK, Vandemaele K, Chungong S, Richer M, Anker M, Ayana Y, et al. Clinical and epidemiologic characteristics of nodding syndrome in Mundri County, South Sudan. Afr Health Sci. 2012;12:242-8.
3. van der Waals F, Goudsmit J, Gajdusek DC. See-ee: clinical characteristics of highly prevalent seizure disorders in the Gbawein and Wroughbarh clan region of Grand Bassa County, Liberia. Neuroepidemiology. 1983;2:35-44. http://dx.doi.org/10.1159/000110508
4. Aall-Jilek LM. Epilepsy in the Wapogoro tribe in Tanganyika. Acta Psychiatr Scand. 1965;41:57-86. http://dx.doi.org/10.1111/ j.1600-0447.1965.tb04970.x
5. Kaiser C, Benninger C, Asaba G, Mugisa C, Kabagambe G, Kipp W, et al. Clinical and electro-clinical classification of epileptic seizure in west Uganda. Bull Soc Pathol Exot. 2000;93:255-9.
6. Foltz J, Makumbi I, Sejvar JJ, Malimbo M, Ndyomugyenyi R, Atai-Omoruto AD, et al. An epidemiologic investigation of potential risk factors for nodding syndrome in Kitgum District, Uganda. PLoS ONE. 2013;8: In press.
7. Sejvar JJ, Kakooza AM, Foltz JL, Makumbi I, Atai-Omoruto AD, Malimbo M, et al. Clinical, neurologic, and electrophysiologic features of nodding syndrome, Kitgum, Uganda: an observational case series. Lancet Neurol. 2013;12:166-74. http://dx.doi. org/10.1016/S1474-4422(12)70321-6
8. Centers for Disease Control and Prevention. Nodding syndrome-South Sudan, 2011. MMWR Morb Mortal Wkly Rep. 2012;61:52-4.
9. Winkler AS, Friedrich K, Konig R, Meindl M, Helbrok R, Unterberger I, et al. The head nodding syndrome: clinical classification and possible causes. Epilepsia. 2008;49:2008-15. http://dx.doi. org/10.1111/j.1528-1167.2008.01671.x
10. Winkler AS, Friedrich K, Meindl M, Kidunda A, Nassri A, Jilek-Aall L, et al. Clinical characteristics of people with head nodding in southern Tanzania. Trop Doct. 2010;40:173-5. http://dx.doi. org/10.1258/td.2010.090373
11. Nyungura JL, Lako A, Gordon A, Lejeng L, William G. Investigation into the nodding syndrome in Witto Payam, Western Equatoria State, 2010. Southern Sudan Medical Journal. 2011;4:3-6.
12. Donnelly J. CDC planning trial for mysterious nodding syndrome. Lancet. 2012;379:299. http://dx.doi.org/10.1016/S0140-6736(12) 60126-3
13. Williams SC. Nodding syndrome leaves baffled scientists shaking their heads. Nat Med. 2012;18:334. http://dx.doi.org/10.1038/ nm0312-334
14. Wasswa H. Ugandan authorities deal with a mysterious ailment that leaves people nodding continuously. BMJ. 2012;344:e349. http://dx.doi.org/10.1136/bmj.e349
15. Fallon A. Hundreds of new nodding disease cases reported. iUganda 2012;Section. Uganda local news story [cited 2013 Jun 4]. http://iuganda.ug/news/local/11793-hundreds-of-new-noddingcases-reported.html
16. World Health Organization. Report of an international conference on nodding syndrome. Bull World Health Organ. 2013;91. In press.
17. Sillanpää M, Shinnar S. Long-term mortality in childhood-onset epilepsy. N Engl J Med. 2010;363:2522-9. http://dx.doi.org/10.1056/ NEJMoa0911610
18. Lin FC, Wei LJ, Shih PY. Effect of levetiracetam on truncal tic in neuroacanthocytosis. Acta Neurol Taiwan. 2006;15:38-42.
19. Noma M, Nwoke BE, Nutall I, Tambala PA, Enyong P, Namsenmo A, et al. Rapid epidemiological mapping of onchocerciasis (REMO): its application by the African Programme for Onchocerciasis Control (APOC). Ann Trop Med Parasitol. 2002;96(Suppl 1):S29-39. http://dx.doi.org/10.1179/000349802125000637
20. World Health Organization Economic and Social Council. Onchocerciasis and its control. Geneva: The Organization; 1995.
21. Sauerbrey M. The Onchocerciasis Elimination Program for the Americas (OEPA). Ann Trop Med Parasitol. 2008;102(Suppl 1): 25-9. http://dx.doi.org/10.1179/136485908X337454
22. Jilek-Aall L, Jilek W, Miller JR. Clinical and genetic aspects of seizure disorders prevalent in an isolated African population. Epilepsia. 1979;20:613-22. http://dx.doi.org/10.1111/j.1528-1157.1979tb04845.x
23. Demirkaya E, Ozen S, Bilginer Y, Ayaz NA, Makay BB, Unsal E, et al. The distribution of juvenile idiopathic arthritis in the eastern Mediterranean: results from the registry of the Turkish Paediatric Rheumatology Association. Clin Exp Rheumatol. 2011;29:111-6.
24. Demiroren K, Yavuz H, Cam L, Oran B, Karaaslan S, Demiroren S. Sydenham's chorea: a clinical follow-up of 65 patients. J Child Neurol. 2007;22:550-4. http://dx.doi.org/10.1177/0883073807302614
25. Bonmarin I, Nunga M, Perea WA. Konzo outbreak, in the southwest of the Democratic Republic of Congo, 1996. J Trop Pediatr. 2002;48:234-8. http://dx.doi.org/10.1093/tropej/48.4.234
26. Getahun H, Mekonnen A. TekleHaimanot R, Lambein F. Epidemic of neurolathyrism in Ethiopia. Lancet. 1999;354:306-7. http://dx.doi.org/10.1016/S0140-6736(99)02532-5
27. Mutonga DM, Pimentel G, Muindi J, Nzioka C, Mutiso J, Klena JD, et al. Epidemiology and risk factors for serogroup X meningococcal meningitis during an outbreak in western Kenya, 2005-2006. Am J Trop Med Hyg. 2009;80:619-24.
28. Morenikej OA, Idowu BA. Studies on the prevalence of urinary schistosomiasis in Ogun State, south-western Nigeria. West Afr J Med. 2011;30:62-5.
29. Barskey AE, Glasser JW, LeBaron CW. Mumps resurgences in the United States: a historical perspective on unexpected elements. Vaccine. 2009;27:6186-95. http://dx.doi.org/10.1016/j. vaccine.2009.06.109
30. Collie DA, Summers DM, Sellar RJ, Ironside JW, Cooper S, Zeidler M, et al. Diagnosing variant Creutzfeldt-Jakob disease with the pulvinar sign: MR imaging findings in 86 neuropathologically confirmed cases. AJNR Am J Neuroradiol. 2003;24:1560-9.
31. Geschwind MD, Shu H, Haman A, Sejvar JJ, Miller BL. Rapidly progressive dementia. Ann Neurol. 2008;64:97-108. http://dx.doi. org/10.1002/ana.21430
32. Basáñez MG, Pion SD, Boakes E, Filipe JA, Churcher TS, Boussinesq M. Effect of single-dose ivermectin on Onchocerca volvulus: a systematic review and meta-analysis. Lancet Infect Dis. 2008;8:310-22. http://dx.doi.org/10.1016/S1473-3099(08)70099-9
33. Pion SD, Kaiser C, Boutros-Toni F, Cournil A, Taylor MM, Meredith SE, et al. Epilepsy in onchocerciasis endemic areas: systematic review and meta-analysis of population-based surveys. PLoS Negl Trop Dis. 2009;3:e461. http://dx.doi.org/10.1371/ journal.pntd.0000461
34. Kaiser C, Rubaale T, Tukesiga E, Kipp W, Kabasambe G, Ojony JO, et al. Association between onchocerciasis and epilepsy in the Itwara hyperendemic focus, West Uganda: controlling for time and intensity of exposure. Am J Trop Med Hyg. 2011;85:225-8. http://dx.doi.org/10.4269/ajtmh.2011.10-0544
35. Katabarwa M, Lakwo T, Habumogisha P, Richards F, Eberhard M. Could neurocysticercosis be the cause of "onchocerciasis-associated" epileptic seizures? Am J Trop Med Hyg. 2008;78:400-1.
36. König R, Nassri A, Meindl M, Matuja W, Kidunda AR, Siegmund V, et al. The role of Onchocerca volvulus in the development of epilepsy in a rural area of Tanzania. Parasitology. 2010;137:1559-68. http://dx.doi.org/10.1017/S0031182010000338
37. Stockler S, Plecko B, Gospe SM Jr, Coulter-Mackie M, Connolly M, van Karnebeek C, et al. Pyridoxine dependent epilepsy and antiquitin deficiency: clinical and molecular characteristics and recommendationsfor diagnosis, treatment and follow-up. Mol Genet Metab. 2011;104:48-60. http://dx.doi. org/10.1016/j.ymgme.2011.05.014
38. Gospe SM Jr. Neonatal vitamin-responsive epileptic encephalopathies. Chang Gung Med J. 2010;33:1-12.
39. Kirvan CA, Swedo SE, Kurahara D, Cunningham MW. Streptococcal mimicry and antibody-mediated cell signaling in the pathogenesis of Sydenham's chorea. Autoimmunity. 2006;39:21-9. http://dx.doi. org/10.1080/08916930500484757
40. Quek AM, Britton JW, McKeon A, So SE, Lennon VA, Shin C, et al. Autoimmune epilepsy: clinical characteristics and response to immunotherapy. Arch Neurol. 2012;69:582-593. http://dx.doi. org/10.1001/archneurol.2011.2985